← Oncology Approval Tracker

FDA DECISION ·

Opdivo

nivolumab · Bristol Myers Squibb

FDA approvalNew or expanded indicationMelanoma
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Adjuvant treatment for patients aged 12 or older after complete resection of stage IIB or IIC melanoma.

LAMPGEN ANALYSIS

Why it matters

The adjuvant indication moved to a node-negative, higher-risk stage group.

What research teams should watch

Verify pathologic stage, resection status and age before applying the label.

PRIMARY RECORDS

Sources